MAXORPTION Trademark

Pharmaceutical and veterinary preparations containing omega 3 for treatment of cardiovascular diseases, cognitive decline, and inflammatory disorders; dietetic foods for medical use containing oils rich in EPA and DHA for treating dyslipidemia, metabolic syndrome, and neurodevelopmental disorders; nutritional supplements for human consumption for medical use containing oils rich in EPA and DHA that are of marine or microalgae origin for treating cardiovascular and metabolic disorders namely hypertriglyceridemia, metabolic syndrome, and type 2 diabetes, neurological and cognitive decline namely Alzheimer's disease and mild cognitive impairment, mood and psychiatric disorders namely depression and anxiety, inflammatory and autoimmune conditions namely rheumatoid arthritis and inflammatory bowel disease, and ophthalmic disorders namely dry eye syndrome and age-related macular degeneration; ophthalmic preparations containing omega-3; food supplements for medical use containing oils rich in EPA and DHA that are of marine or microalgae origin for treating cardiovascular diseases namely hypertriglyceridemia and atherosclerosis, neurodegenerative disorders namely Alzheimer's disease and cognitive decline, psychiatric conditions namely depression and anxiety, inflammatory and autoimmune diseases namely rheumatoid arthritis, and for supporting maternal and infant health namely healthy pregnancy, reduction of risk of preterm birth, optimal fetal brain and retinal development, and post-partum mental health; food supplements for specialized nutrition, infant nutrition; Nutraceuticals containing oils rich in EPA and DHA, targeting the microbiota for treating inflammatory bowel disease, irritable bowel syndrome and metabolic inflammation and intestinal dysbiosis; Nutritional dietetic food additives for medical, paramedical or pharmaceutical use in the nature of natural food extracts derived from fish; food supplements containing omega-3; food supplements derived from microalgae or marine oils